Find Apaziquone manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 114560-48-4, Eoquin, Qapzola, Eo-9, Nor-701, Nsc-382459
Molecular Formula
C15H16N2O4
Molecular Weight
288.30  g/mol
InChI Key
MXPOCMVWFLDDLZ-NSCUHMNNSA-N
FDA UNII
H464ZO600O

Apaziquone
Apaziquone is an indolequinone bioreductive prodrug and analog of mitomycin C with potential antineoplastic and radiosensitization activities. Apaziquone is converted to active metabolites in hypoxic cells by intracellular reductases, which are present in greater amounts in hypoxic tumor cells. The active metabolites alkylate DNA, resulting in apoptotic cell death. This agent displays selectivity activity towards both hypoxic solid tumors, which exhibits higher expression of cytochrome P450 reductase, and well-oxygenated malignant cells that overexpress the bioreductive enzyme NQO1 (NAD(P)H: quinone oxidoreductase). Apaziquone may selectively sensitize hypoxic tumor cells to radiocytotoxicity.
1 2D Structure

Apaziquone

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-(aziridin-1-yl)-3-(hydroxymethyl)-2-[(E)-3-hydroxyprop-1-enyl]-1-methylindole-4,7-dione
2.1.2 InChI
InChI=1S/C15H16N2O4/c1-16-10(3-2-6-18)9(8-19)13-14(16)12(20)7-11(15(13)21)17-4-5-17/h2-3,7,18-19H,4-6,8H2,1H3/b3-2+
2.1.3 InChI Key
MXPOCMVWFLDDLZ-NSCUHMNNSA-N
2.1.4 Canonical SMILES
CN1C(=C(C2=C1C(=O)C=C(C2=O)N3CC3)CO)C=CCO
2.1.5 Isomeric SMILES
CN1C(=C(C2=C1C(=O)C=C(C2=O)N3CC3)CO)/C=C/CO
2.2 Other Identifiers
2.2.1 UNII
H464ZO600O
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 3-hydroxymethyl-5-aziridinyl-1-methyl-2-(1h-indole-4,7-dione)prop-beta-en-alpha-ol

2. 5-(azridin-1-yl)-3-(hydroxymethyl)-2-((1e)-3-hydroxyprop-1-enyl)-methyl-1h-indole-4,7-dione

3. E 09

4. E-09

5. Eo 9

6. Eo-9

7. Eo9

8. Nsc 382,459

9. Nsc 382459

10. Nsc-382459

11. Qapzola

2.3.2 Depositor-Supplied Synonyms

1. 114560-48-4

2. Eoquin

3. Qapzola

4. Eo-9

5. Nor-701

6. Nsc-382459

7. 5-(aziridin-1-yl)-3-(hydroxymethyl)-2-[(e)-3-hydroxyprop-1-enyl]-1-methylindole-4,7-dione

8. E-85/053

9. Eo9

10. 141304-51-0

11. 5-(azridin-1-yl)-3-(hydroxymethyl)-2-((1e)-3-hydroxyprop-1-enyl)-methyl-1h-indole-4,7-dione

12. Apaziquonum

13. H464zo600o

14. Nsc-382456

15. Neoquin

16. Eo 9 (pharmaceutical)

17. Apaziquone [usan:inn]

18. Apaziquonum [inn-latin]

19. 1h-indole-4,7-dione, 5-(1-aziridinyl)-3-(hydroxymethyl)-2-((1e)-3-hydroxy-1-propenyl)-1-methyl-

20. E09

21. E 09

22. 5-aziridin-1-yl-3-hydroxymethyl-2-((e)-3-hydroxy-propenyl)-1-methyl-1h-indole-4,7-dione

23. Nsc 382459

24. Eoquin (tn)

25. E-09

26. Apaziquone (usan/inn)

27. Nsc 382456

28. Unii-h464zo600o

29. 1h-indole-4,7-dione, 5-(1-aziridinyl)-3-(hydroxymethyl)-2-[(1e)-3-hydroxy-1-propen-1-yl]-1-methyl-

30. Apaziquone [usan]

31. (e)-5-(1-azirinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1h-indole-4,7-dione

32. Apaziquone [mi]

33. Apaziquone [inn]

34. 1h-indole-4,7-dione, 5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-, (e)-

35. Chembl73822

36. Schembl367964

37. Schembl367965

38. E-85/050

39. Antineoplastic-382459

40. Dtxsid90869587

41. Chebi:177558

42. Zinc1536777

43. N1,n6-diethyl-3-methylhexanediamide

44. Nsc382459

45. Bcp9000309

46. Db12593

47. Cs-0006128

48. D02965

49. Q4779259

50. 1h-indole-4, 5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-

51. 5-(aziridin-1-yl)-3-(hydroxymethyl)-2-(3-hydroxyprop-1-enyl)-1-methylindole-4,7-dione

52. (e)-5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1h-indole-4,7-dione

53. 5-(1-aziridinyl)-3-(hydroxymethyl)-2-[(1e)-3-hydroxy-1-propen-1-yl]-1-methyl-1h-indole-4,7-dione

54. 5-(1-aziridinyl)-3-(hydroxymethyl)-2-[(1e)-3-hydroxy-1-propen-1-yl]-1-methyl-1h-indole-4,7-dione;

2.4 Create Date
2005-09-08
3 Chemical and Physical Properties
Molecular Weight 288.30 g/mol
Molecular Formula C15H16N2O4
XLogP3-0.5
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count4
Exact Mass288.11100700 g/mol
Monoisotopic Mass288.11100700 g/mol
Topological Polar Surface Area82.5 Ų
Heavy Atom Count21
Formal Charge0
Complexity524
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antineoplastic Agents

Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)


ABOUT THIS PAGE

Looking for 114560-48-4 / Apaziquone API manufacturers, exporters & distributors?

Apaziquone manufacturers, exporters & distributors 1

45

PharmaCompass offers a list of Apaziquone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Apaziquone manufacturer or Apaziquone supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Apaziquone manufacturer or Apaziquone supplier.

PharmaCompass also assists you with knowing the Apaziquone API Price utilized in the formulation of products. Apaziquone API Price is not always fixed or binding as the Apaziquone Price is obtained through a variety of data sources. The Apaziquone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Apaziquone

Synonyms

114560-48-4, Eoquin, Qapzola, Eo-9, Nor-701, Nsc-382459

Cas Number

114560-48-4

Unique Ingredient Identifier (UNII)

H464ZO600O

About Apaziquone

Apaziquone is an indolequinone bioreductive prodrug and analog of mitomycin C with potential antineoplastic and radiosensitization activities. Apaziquone is converted to active metabolites in hypoxic cells by intracellular reductases, which are present in greater amounts in hypoxic tumor cells. The active metabolites alkylate DNA, resulting in apoptotic cell death. This agent displays selectivity activity towards both hypoxic solid tumors, which exhibits higher expression of cytochrome P450 reductase, and well-oxygenated malignant cells that overexpress the bioreductive enzyme NQO1 (NAD(P)H: quinone oxidoreductase). Apaziquone may selectively sensitize hypoxic tumor cells to radiocytotoxicity.

Apaziquone Manufacturers

A Apaziquone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Apaziquone, including repackagers and relabelers. The FDA regulates Apaziquone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Apaziquone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Apaziquone Suppliers

A Apaziquone supplier is an individual or a company that provides Apaziquone active pharmaceutical ingredient (API) or Apaziquone finished formulations upon request. The Apaziquone suppliers may include Apaziquone API manufacturers, exporters, distributors and traders.

click here to find a list of Apaziquone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Apaziquone USDMF

A Apaziquone DMF (Drug Master File) is a document detailing the whole manufacturing process of Apaziquone active pharmaceutical ingredient (API) in detail. Different forms of Apaziquone DMFs exist exist since differing nations have different regulations, such as Apaziquone USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Apaziquone DMF submitted to regulatory agencies in the US is known as a USDMF. Apaziquone USDMF includes data on Apaziquone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Apaziquone USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Apaziquone suppliers with USDMF on PharmaCompass.

Apaziquone GMP

Apaziquone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Apaziquone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Apaziquone GMP manufacturer or Apaziquone GMP API supplier for your needs.

Apaziquone CoA

A Apaziquone CoA (Certificate of Analysis) is a formal document that attests to Apaziquone's compliance with Apaziquone specifications and serves as a tool for batch-level quality control.

Apaziquone CoA mostly includes findings from lab analyses of a specific batch. For each Apaziquone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Apaziquone may be tested according to a variety of international standards, such as European Pharmacopoeia (Apaziquone EP), Apaziquone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Apaziquone USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty